Capital World Investors »

Revance Therapeutics shares owned by Capital World Investors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Capital World Investors

Quarter filed Position value Share count Share price at filing
2023-09-30 $137M 12M 11.47
2023-06-30 $242M 9.6M 25.31
2023-03-31 $325M 10M 32.21
2022-12-31 $175M 9.5M 18.46
2022-03-31 $65M 3.4M 19.50
2021-12-31 $61M 3.7M 16.32
2021-09-30 $83M 3.0M 27.86
2021-06-30 $88M 3.0M 29.64
2021-03-31 $72M 2.6M 27.95
2020-12-31 $60M 2.1M 28.34
2020-09-30 $54M 2.1M 25.14
2020-06-30 $52M 2.1M 24.42
2020-03-31 $32M 2.1M 14.80
2019-12-31 $35M 2.1M 16.23
2019-09-30 $22M 1.7M 13.00
2019-03-31 $27M 1.7M 15.76
2018-12-31 $25M 1.2M 20.13
2018-09-30 $30M 1.2M 24.85
2018-06-30 $39M 1.4M 27.45